GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BRIM Biotechnology 6885.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

27.50

+3.19%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2023

Revenue

TWD 90,000

FY2019FY2023

Net income

−TWD 688.0m

FY2019FY2023

Free cash flow

−TWD 600.6m

FY2019FY2023

Shareholders' equity

TWD 1.74bn

FY2019FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2019
RevenueTWD 90,000TWD 526,000TWD 360,000TWD 90.8m—
Gross profitTWD 90,000TWD 526,000TWD 360,000TWD 90.8m—
Research and developmentTWD 582.0mTWD 146.0mTWD 48.6mTWD 205.8mTWD 85.3m
Operating income−TWD 687.9m−TWD 274.2m−TWD 105.3m−TWD 96.9m−TWD 125.1m
Net income−TWD 688.0m−TWD 274.3m−TWD 105.4m−TWD 87.9m−TWD 118.8m
Diluted earnings per share-6.84-3.72-1.72-1.33-2.02

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019
Total assetsTWD 1.78bnTWD 940.0mTWD 495.4mTWD 317.3mTWD 445.8m
Cash and short-term investmentsTWD 1.70bnTWD 838.0mTWD 423.6mTWD 169.4mTWD 86.4m
Total liabilitiesTWD 42.2mTWD 25.3mTWD 17.6mTWD 53.5mTWD 16.0m
DebtTWD 3.6mTWD 6.4mTWD 3.2mTWD 6.2mTWD 2.8m
Shareholders' equityTWD 1.74bnTWD 914.7mTWD 477.9mTWD 263.8mTWD 347.0m
Shares outstanding101m74m61m66m59m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2019
Cash from operations−TWD 596.9m−TWD 171.9m−TWD 112.6m−TWD 127.1m−TWD 114.1m
Capital spending−TWD 3.7m−TWD 1.2m−TWD 514,000−TWD 366,000−TWD 69,000
Free cash flow−TWD 600.6m−TWD 173.1m−TWD 113.1m−TWD 127.5m−TWD 114.1m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
RevenueTWD 1.2mTWD 1.6mTWD 100,000TWD 22,000TWD 6,000——TWD 45,000
Gross profit−TWD 161,000TWD 1.5mTWD 10,000————TWD 45,000
Operating income−TWD 104.4m−TWD 83.2m−TWD 79.2m−TWD 190.0m−TWD 65.0m−TWD 94.0m−TWD 38.0m−TWD 268.9m
Net income−TWD 83.8m−TWD 121.3m−TWD 69.9m−TWD 183.0m−TWD 71.0m−TWD 94.0m−TWD 38.0m−TWD 263.9m
Diluted earnings per share-0.63-0.92-0.53-1.56-0.61-0.71-0.29-2.45
Cash from operations—————−TWD 97.0m−TWD 48.0m−TWD 226.0m
Capital spending——————−TWD 1.0m—
Free cash flow——————−TWD 49.0m—
Total assetsTWD 1.93bnTWD 2.21bnTWD 2.35bnTWD 2.41bnTWD 1.57bnTWD 1.64bnTWD 1.74bnTWD 1.78bn
Cash and short-term investmentsTWD 1.28bnTWD 1.66bnTWD 1.79bnTWD 1.85bnTWD 1.46bnTWD 1.56bnTWD 1.66bnTWD 1.70bn
DebtTWD 8.9mTWD 3.0mTWD 2.5mTWD 3.5m—TWD 1.5mTWD 2.5mTWD 3.5m
Shareholders' equityTWD 1.80bnTWD 1.88bnTWD 1.99bnTWD 2.06bnTWD 1.55bnTWD 1.62bnTWD 1.71bnTWD 1.74bn

Financial ratios

Data as of 21 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin22.8%6.6%100.0%100.0%100.0%
Operating margin-8204.2%-94708.4%-764300.0%-52128.9%-25893.1%
Net margin-7949.9%-94735.7%-764468.9%-52143.9%-29291.4%
Return on equity-26.4%-15.3%-39.6%-30.0%-22.1%
Return on assets-23.9%-13.1%-38.7%-29.2%-21.3%
Free cash flow yield-0.1%-5.1%———
Revenue growth1548.6%270.0%-82.9%46.1%—
Earnings growth38.3%-54.1%150.8%160.1%—
Current ratio18.06x5.35x40.74x37.76x24.99x
Debt to equity0.00x0.00x———
Equity ratio90.5%85.3%97.6%97.3%96.5%
Interest coverage-906.26x-3465.70x-4525.46x-3470.86x-839.77x
R&D as a share of sales6020.8%71620.4%646643.3%27755.3%13500.6%
Buybacks as a share of market value-1.3%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-60.6%——
Operating income48.5%22.5%—
Net income44.1%21.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-922013.4%-141502.1%——
Net margin-895975.0%-138599.0%——

Valuation history

At each fiscal year end

FY2024FY2023FY2022
Price to earnings-11.5-4.3-4.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.